scispace - formally typeset
R

Rajiv Kumar

Researcher at Institute of Medical Sciences, Banaras Hindu University

Publications -  45
Citations -  2222

Rajiv Kumar is an academic researcher from Institute of Medical Sciences, Banaras Hindu University. The author has contributed to research in topics: Visceral leishmaniasis & Immune system. The author has an hindex of 24, co-authored 45 publications receiving 1836 citations. Previous affiliations of Rajiv Kumar include Banaras Hindu University & Netaji Subhas Institute of Technology.

Papers
More filters
Journal ArticleDOI

Immunobiology of visceral leishmaniasis

TL;DR: In this review, immunological events described in human and experimental VL and how these can affect the outcome of infection are discussed.
Journal ArticleDOI

IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis.

TL;DR: Findings provide direct support for targeting IL-10 as an approach to therapy in human VL and promote parasite killing in 73% and complete clearance in 30%, while 18% had more parasites and 9% did not change.
Journal ArticleDOI

Vaccines to prevent leishmaniasis

TL;DR: The understanding of host immunity following Leishmania infection is reviewed and recent advances in the development of vaccines to prevent leishmaniasis are discussed, highlighting a new promising approach that targets the parasite hemoglobin receptor.
Journal ArticleDOI

IL-27 and IL-21 are Associated with T Cell IL-10 Responses in Human Visceral Leishmaniasis

TL;DR: Proinflammatory cytokines acting on macrophages in the VL spleen have the potential to upregulate IL-27, which in turn can induce IL-21 to expand IL-10–producing T cells as a mechanism of feedback control.
Journal ArticleDOI

CD8 T Cell Exhaustion in Human Visceral Leishmaniasis

TL;DR: CD8 T cells are driven to anergy/exhaustion in human VL, which affect their ability to contribute to protective immune responses, andGene and surface marker expression suggest that splenic CD8 cell predominantly display an anergic phenotype, whereas CD8-PBMC have features of both anergic cells and CTLs.